Results 21 to 30 of about 25,062 (184)
Chemokine receptor Ccr1 drives neutrophil-mediated kidney immunopathology and mortality in invasive candidiasis. [PDF]
PLoS Pathogens, 2012 Invasive candidiasis is the 4(th) leading cause of nosocomial bloodstream infection in the US with mortality that exceeds 40% despite administration of antifungal therapy; neutropenia is a major risk factor for poor outcome after invasive candidiasis. In
Michail S Lionakis +9 more
doaj +2 more sources
MicRobiological diagnosis of invasive candidiasis [PDF]
Zdravniški Vestnik, 2009 background Candida spp. are responsible for opportunistic fungal infections in patients with known risk factors. Clinical diagnosis of invasive candidiasis is difficult because clinical features and symptoms are usually non-specific.
Eva Sodja, Tadeja Matos, Saša Simčič
doaj +2 more sources
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mediterranean Journal of Hematology and Infectious Diseases, 2011 Candida is one of the most frequent pathogens isolated in bloodstream infections, and is associated with significant morbidity and mortality. In addition to haematological patients, there are several other populations with a substantial risk of ...
Malgorzata Mikulska +3 more
doaj +4 more sources
Seminars in Respiratory and Critical Care Medicine, 2020 AbstractInvasive candidiasis (IC) is the most frequent health care associated invasive fungal infection. It is also associated with high morbidity, mortality, and cost. The most frequent etiologic agent is Candida albicans, but non-albicans species are increasing and associated with reduced antifungal susceptibility and outbreaks.
María F, Gonzalez-Lara +1 more
+5 more sources
Current treatment methods for invasive candidiasis in donor organ recipients (part I) [PDF]
Инновационная медицина Кубани, 2019 In donor organ recipients development of invasive fungous infections, the majority of which is caused by Candida spp and Aspergillus spp, significantly increases. Invasive candidiasis clinical signs are diverse and this fact complicates early diagnostics.
E. V. Bolotova +5 more
doaj +4 more sources
Nature Reviews Disease Primers, 2018 Invasive candidiasis is an important health-care-associated fungal infection that can be caused by several Candida spp.; the most common species is Candida albicans, but the prevalence of these organisms varies considerably depending on geographical location.
Pappas, Peter G. +4 more
openaire +6 more sources
New England Journal of Medicine, 2015 Contains fulltext : 152392.pdf (Publisher’s version ) (Open Access)
Bosch, Barbara +2 more
openaire +8 more sources
Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. [PDF]
, 2016 Every year, Candida, Aspergillus, Cryptococcus and Pneumocystis infect an estimated two million individuals worldwide. Most are immunocompromised or critically ill.
Stephan Zimmerli +3 more
core +1 more source
Academia Biology, 2023 Background to the study: Invasive candidiasis is a critical healthcare-related fungal infection caused by several Candida species. Candida auris is an emerging multidrug-resistant, non-albicans species responsible for nosocomial infections ...
Hassan Yahaya, Hamza Sule
doaj +1 more source
Comparison of caspofungin and amphotericin B for invasive candidiasis. [PDF]
, 2002 Background: Caspofungin is an echinocandin agent with fungicidal activity against candida species. We performed a double-blind trial to compare caspofungin with amphotericin B deoxycholate for the primary treatment of invasive candidiasis.Methods: We ...
Colombo, A. L. +10 more
core +1 more source